MicroRNAs in neuronal function and dysfunction

Trends in Neurosciences

Volumn 35, Issue 5, 2012, Pages 325-334

  Im, Heh In ^a   Kenny, Paul J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Addiction; Depression; MicroRNA; Noncoding RNA; Rett syndrome; Schizophrenia

Indexed keywords

MICRORNA;

AUTISM; BRAIN DEVELOPMENT; BRAIN FUNCTION; DEPRESSION; DRUG DEPENDENCE; FRAGILE X SYNDROME; GENE EXPRESSION; HUMAN; MENTAL DISEASE; NERVE FUNCTION; NEUROLOGIC DISEASE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; SCHIZOPHRENIA;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEURONS;

EID: 84860388339     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2012.01.004     Document Type: Review

References (128)

1. Kapsimali M., et al. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 2007, 8:R173.
2. Cheng L.C., et al. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 2009, 12:399-408.
3. Liu C., et al. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell 2010, 6:433-444.
4. Giraldez A.J., et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005, 308:833-838.
5. Davis T.H., et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 2008, 28:4322-4330.
6. Schaefer A., et al. Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J. Exp. Med. 2010, 207:1843-1851.
7. Kawase-Koga Y., et al. Different timings of Dicer deletion affect neurogenesis and gliogenesis in the developing mouse central nervous system. Dev. Dyn. 2009, 238:2800-2812.
8. Huang T., et al. Wnt1-cre-mediated conditional loss of Dicer results in malformation of the midbrain and cerebellum and failure of neural crest and dopaminergic differentiation in mice. J. Mol. Cell Biol. 2010, 2:152-163.
9. Bilen J., et al. A new role for microRNA pathways: modulation of degeneration induced by pathogenic human disease proteins. Cell Cycle 2006, 5:2835-2838.
10. Hebert S.S., et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum. Mol. Genet. 2010, 19:3959-3969.
11. Martino S., et al. MicroRNA implications across neurodevelopment and neuropathology. J. Biomed. Biotechnol. 2009, 2009:654346.
12. Vo N.K., et al. MicroRNA pathways in neural development and plasticity. Curr. Opin. Neurobiol. 2010, 20:457-465.
13. Zhang J., et al. Effects of miR-541 on neurite outgrowth during neuronal differentiation. Cell Biochem. Funct. 2011, 29:279-286.
14. Abdelmohsen K., et al. miR-375 inhibits differentiation of neurites by lowering HuD levels. Mol. Cell. Biol. 2010, 30:4197-4210.
15. Smrt R.D, et al. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 2010, 28:1060-1070.
16. Kole A.J., et al. miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev. 2011, 25:125-130.
17. Gaughwin P., et al. Stage-specific modulation of cortical neuronal development by Mmu-miR-134. Cereb. Cortex 2011, 21:1857-1869.
18. Chen H., et al. miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro. Biochem. Biophys. Res. Commun. 2010, 394:921-927.
19. Balzer E., et al. LIN28 alters cell fate succession and acts independently of the let-7 microRNA during neurogliogenesis in vitro. Development 2010, 137:891-900.
20. Coolen M., Bally-Cuif L. MicroRNAs in brain development and physiology. Curr. Opin. Neurobiol. 2009, 19:461-470.
21. Sanuki R., et al. miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. Nat. Neurosci. 2011, 14:1125-1134.
22. Mellios N., et al. miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity. Nat. Neurosci. 2011, 14:1240-1242.
23. Tognini P., et al. Experience-dependent expression of miR-132 regulates ocular dominance plasticity. Nat. Neurosci. 2011, 14:1237-1239.
24. Smirnova L., et al. Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 2005, 21:1469-1477.
25. Conaco C., et al. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2422-2427.
26. Battaglioli E., et al. REST repression of neuronal genes requires components of the hSWI.SNF complex. J. Biol. Chem. 2002, 277:41038-41045.
27. Andres M.E., et al. CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9873-9878.
28. Visvanathan J., et al. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 2007, 21:744-749.
29. Makeyev E.V., et al. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 2007, 27:435-448.
30. Cao X., et al. A functional study of miR-124 in the developing neural tube. Genes Dev. 2007, 21:531-536.
31. Konopka W., et al. MicroRNA loss enhances learning and memory in mice. J. Neurosci. 2010, 30:14835-14842.
32. Cougot N., et al. Dendrites of mammalian neurons contain specialized P-body-like structures that respond to neuronal activation. J. Neurosci. 2008, 28:13793-13804.
33. Ashraf S.I., et al. Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila. Cell 2006, 124:191-205.
34. Banerjee S., et al. A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation. Neuron 2009, 64:871-884.
35. Krol J., et al. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 2010, 141:618-631.
36. Nudelman A.S., et al. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132 in vivo. Hippocampus 2010, 20:492-498.
37. Vo N., et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16426-16431.
38. Edbauer D., et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010, 65:373-384.
39. Magill S.T., et al. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20382-20387.
40. Hansen K.F., et al. Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory. PLoS ONE 2010, 5:e15497.
41. Impey S., et al. An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling. Mol. Cell. Neurosci. 2010, 43:146-156.
42. Wayman G.A., et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9093-9098.
43. Hollander J.A., et al. Striatal microRNA controls cocaine intake through CREB signalling. Nature 2010, 466:197-202.
44. Lambert T.J., et al. MicroRNA132 modulates short-term synaptic plasticity but not basal release probability in hippocampal neurons. PLoS ONE 2010, 5:e15182.
45. Cheng H.Y., et al. microRNA modulation of circadian-clock period and entrainment. Neuron 2007, 54:813-829.
46. Gao J., et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010, 466:1105-1109.
47. O'Neill L.A. Boosting the brain's ability to block inflammation via microRNA-132. Immunity 2009, 31:854-855.
48. Strum J.C., et al. MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1. Mol. Endocrinol. 2009, 23:1876-1884.
49. Zovoilis A., et al. microRNA-34c is a novel target to treat dementias. EMBO J. 2011, 30:4299-4308.
50. Fiore R., et al. Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J. 2009, 28:697-710.
51. Schratt G.M., et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439:283-289.
52. Christensen M., et al. Recombinant adeno-associated virus-mediated microRNA delivery into the postnatal mouse brain reveals a role for miR-134 in dendritogenesis in vivo. Front. Neural Circuits 2010, 3:16.
53. Siegel G., et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat. Cell Biol. 2009, 11:705-716.
54. Rajasethupathy P., et al. Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 2009, 63:803-817.
55. Cheever A., Ceman S. Translation regulation of mRNAs by the fragile X family of proteins through the microRNA pathway. RNA Biol. 2009, 6:175-178.
56. Jin P., et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat. Neurosci. 2004, 7:113-117.
57. Xu X.L., et al. The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMR1 in Drosophila. J. Neurosci. 2008, 28:11883-11889.
58. Muddashetty R.S., et al. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol. Cell 2011, 42:673-688.
59. Xu X.L., et al. FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124. J. Neurosci. 2011, 31:13705-13709.
60. Kondo M., et al. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome - Mecp2 gene dosage effects and BDNF expression. Eur. J. Neurosci. 2008, 27:3342-3350.
61. Klein M.E., et al. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat. Neurosci. 2007, 10:1513-1514.
62. Im H.I., et al. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat. Neurosci. 2010, 13:1120-1127.
63. Wada R., et al. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int. J. Cancer 2010, 127:1106-1114.
64. Abu-Elneel K., et al. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 2008, 9:153-161.
65. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 2006, 7:137-151.
66. Saus E., et al. Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia. Hum. Mol. Genet. 2010, 19:4017-4025.
67. Xu Y., et al. A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform. J. Affect. Disord. 2010, 127:332-336.
68. Baudry A., et al. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010, 329:1537-1541.
69. Beveridge N.J., et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum. Mol. Genet. 2008, 17:1156-1168.
70. Santarelli D.M., et al. Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry 2011, 69:180-187.
71. Beveridge N.J., et al. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 2010, 15:1176-1189.
72. Hansen T., et al. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2007, 2:e873.
73. Xu Y., et al. MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia. Schizophr. Res. 2010, 119:219-227.
74. Sun G., et al. SNPs in human miRNA genes affect biogenesis and function. RNA 2009, 15:1640-1651.
75. Feng J., et al. Evidence for X-chromosomal schizophrenia associated with microRNA alterations. PLoS ONE 2009, 4:e6121.
76. Ripke S., et al. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43:969-976.
77. Karayiorgou M., et al. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 2010, 11:402-416.
78. Stark K.L., et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 2008, 40:751-760.
79. Schofield C.M., et al. Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex. Neural Dev. 2011, 6:11.
80. Kocerha J., et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3507-3512.
81. Mohn A.R., et al. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436.
82. Carlezon W.A., et al. Regulation of cocaine reward by CREB. Science 1998, 282:2272-2275.
83. Sathyan P., et al. Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J. Neurosci. 2007, 27:8546-8557.
84. Tang Y., et al. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol. Clin. Exp. Res. 2008, 32:355-364.
85. Pietrzykowski A.Z., et al. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 2008, 59:274-287.
86. Levitan I.B. miXED messages in ion channel modulation. Neuron 2008, 59:188-189.
87. Liu X.Q., et al. Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles. Mol. Pharm. 2011, 8:250-259.
88. Wiggins J.F., et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 2010, 70:5923-5930.
89. Takeshita F., et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol. Ther. 2010, 18:181-187.
90. Kota J., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.
91. Elmen J., et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.
92. Lanford R.E., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
93. Alvarez-Erviti L., et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 2011, 29:341-345.
94. Li Y., et al. Emergence of chemical biology approaches to the RNAi/miRNA pathway. Chem. Biol. 2010, 17:584-589.
95. Melo S., et al. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4394-4399.
96. Shan G., et al. A small molecule enhances RNA interference and promotes microRNA processing. Nat. Biotechnol. 2008, 26:933-940.
97. Zhang Q., et al. Enhancement of RNAi by a small molecule antibiotic enoxacin. Cell Res. 2008, 18:1077-1079.
98. Watashi K., et al. Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J. Biol. Chem. 2010, 285:24707-24716.
99. Gumireddy K., et al. Small-molecule inhibitors of microrna miR-21 function. Angew. Chem. Int. Ed. Engl. 2008, 47:7482-7484.
100. Young D.D., et al. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J. Am. Chem. Soc. 2010, 132:7976-7981.
101. Jensen K.P., et al. A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol. Psychiatry 2009, 14:381-389.
102. Moreau M.P., et al. Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 2011, 69:188-193.
103. Lippi G., et al. Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology. J. Cell Biol. 2011, 194:889-904.
104. Wu H., et al. Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18161-18166.
105. Szulwach K.E., et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol. 2010, 189:127-141.
106. Urdinguio R.G., et al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010, 5:656-663.
107. Nomura T., et al. MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Hum. Mol. Genet. 2008, 17:1192-1199.
108. Alvarez-Saavedra M., et al. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum. Mol. Genet. 2011, 20:731-751.
109. Kuhn D.E., et al. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J. Biol. Chem. 2010, 285:1529-1543.
110. Lin S.L., et al. Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res. 2011, 39:1054-1065.
111. Burmistrova O.A., et al. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc.) 2007, 72:578-582.
112. Sarachana T., et al. Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med. 2010, 2:23.
113. Uchida S., et al. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur. J. Neurosci. 2008, 27:2250-2261.
114. Beveridge N.J., Cairns M.J. MicroRNA dysregulation in schizophrenia. Neurobiol. Dis. 2011, 10.1016/j.nbd.2011.12.029.
115. Perkins D.O., et al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 2007, 8:R27.
116. Kim A.H., et al. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr. Res. 2010, 124:183-191.
117. Chandrasekar V., Dreyer J.L. Regulation of MiR-124, Let-7d, and MiR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference. Neuropsychopharmacology 2011, 36:1149-1164.
118. Chandrasekar V., Dreyer J.L. microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol. Cell. Neurosci. 2009, 42:350-362.
119. Wu Q., et al. Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b. FASEB J. 2008, 22:4085-4095.
120. Wu Q., et al. Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol. Pharmacol. 2009, 75:744-750.
121. He Y., et al. Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J. Neurosci. 2010, 30:10251-10258.
122. Dave R.S., Khalili K. Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system. J. Cell. Biochem. 2010, 110:834-845.
123. Zheng H., et al. Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability. J. Neurosci. 2010, 30:8102-8110.
124. Zheng H., et al. Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression. J. Biol. Chem. 2010, 285:21994-22002.
125. Zheng H., et al. mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. Mol. Pharmacol. 2010, 77:102-109.
126. *, which targets the 3'-untranslated region of dynamin 1 gene (Dnm1). Int. J. Neuropsychopharmacol. 2009, 12:537-546.
127. Shin V.Y., et al. NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 2011, 32:240-245.
128. Shan H., et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc. Res. 2009, 83:465-472.